Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Mary K. Goldstein, MD MS
VA Palo Alto Health Care System, Palo Alto, CA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Palo Alto Health Care System, Palo Alto, Ca
Palo Alto, California, United States
- San Francisco Va Medical Center, San Francisco, Ca
San Francisco, California, United States
- Durham Va Medical Center, Durham, Nc
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 30 Sept 2005
- Last update posted
- 7 Apr 2015
- Registered enrollment
- 190
- Registry id
- NCT00122161
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.